Table 4.
Adjuvant therapy.
| Cases | Pretreatment | Maximal dose, (mg) | Combined antifungal drugs | Posaconazole serum concentration, (μg/mL) | Liver protection drugs | |
|---|---|---|---|---|---|---|
| DXM | Promethazine | |||||
| 1 | DXM; Promethazine | 5 | 25 | AmB; Posaconazole | >5.00 | GSH |
| 2 | DXM; Promethazine | 5 | 25 | AmB; Posaconazole; Voriconazole | 2.57 | GSH; MgIG |
| 3 | DXM; Promethazine | 5 | 25 | AmB; Posaconazole | 1.89 | GSH |
| 4 | DXM; Promethazine | 5 | 10 | AmB; Posaconazole | 2.43 | GSH; MgIG |
| 5 | DXM; Promethazine | 5 | 25 | AmB; Posaconazole | 2.24 | GSH; MgIG; DG |
| 6 | DXM; Promethazine | 5 | 25 | AmB; Posaconazole; Voriconazole | 0.61 | GSH; MgIG |
| 7 | DXM; Promethazine | 5 | 25 | AmB; Posaconazole | 2.25 | GSH |
| 8 | DXM; Promethazine | 5 | 10 | Posaconazole | 1.22 | GSH; MgIG; Bicyclol |
| 9 | DXM; Promethazine | 2 | 25 | AmB; Posaconazole | 1.96 | None |
DXM, dexamethasone; AmB, Amphotericin B; GSH, glutathione; MgIG, magnesium isoglycyrrhizinate; DG, diammonium glycyrrhizinate.